Glucose Buddy+ for Diabetes vs its rivals

Side-by-side comparison against Glucose Buddy+ for Diabetes's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

Kardia
Peer
Core Identity
DeveloperAzumio Inc.mySugr GmbHMediSafe Inc.Abbott LabsLifeScan, Inc.VoluntisAliveCor, Inc.Spruce Healthathenahealth
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformiOSiOS, AndroidiOSiOS, AndroidAndroid, iOSiOS, AndroidiOS, AndroidiOS, AndroidiOS, Android
Store Metrics
Rating4.8 / 54.7 / 54.7 / 54.6 / 54.8 / 54.8 / 54.8 / 54.9 / 54.9 / 5
Ratings Count3,41230,73199,626105,459157,96439,656210,89587,966133,878
PriceUSD1.99FreeFreeFreeFreeFreeFreeFreeFree
Release DateJun 10, 2012Jun 3, 2013Nov 8, 2012Mar 31, 2025Nov 8, 2013Mar 27, 2015Jan 6, 2013Feb 26, 2016Nov 16, 2022
Last UpdatedJan 5, 2026Apr 12, 2026Feb 10, 2026Jan 16, 2026Dec 4, 2025Apr 14, 2026Apr 15, 2026Apr 8, 2026Apr 17, 2026
Sentiment & Reviews
Sentimentnegative-terriblemixed-----
Score35/100-25/10045/100-----
Praises
  • Tracking blood sugar and medication logs provides essential health management for daily users
-
  • Reliable medication reminders provide essential daily support for managing complex health schedules
  • Real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day
-----
Complaints
  • Aggressive paywall transitions restrict access to previously free historical data and insights
-
  • Frequent application crashes and interface freezes prevent users from logging medication doses
  • Aggressive transition to a paid subscription model locks users out of existing data
  • Frequent Bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking
-----
Requests
  • Expanded integration with fitness trackers and health platforms to automate activity data
--
  • Integration with Apple Health is requested to centralize glucose data with other health metrics
-----
Strategic Intel
Strengths
  • Ten-year brand authority in diabetes management
  • Clinical-grade PDF reporting for healthcare providers
-
  • Clinical-grade drug interaction engine
  • Deep integration with US health infrastructure
  • Multi-user family sync
  • Proprietary sensor-hardware integration creates high switching costs
  • LibreView clinical data management drives provider-led prescription volume
-----
Weaknesses
  • Technical instability during log entry
  • Paywall friction for historical data access
  • Unresponsive customer support
-
  • High crash frequency post-update
  • Mandatory paywall for historical data
  • Inconsistent notification reliability
  • Frequent Bluetooth connection drops
  • Lack of Apple Health data syncing
  • 0.7★ Android-iOS rating gap
-----
Pricingsubscriptionfreemiumfreemiumfreefreefreemiumfreemiumfreemiumfree
MomentumSteadyIntenseActive-SteadyIntenseIntenseIntenseActive
Update Cadence5 versions5 versions5 versions, ~11d avg-5 versions5 versions5 versions5 versions5 versions

Compare Glucose Buddy+ for Diabetes head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Glucose Buddy+ for Diabetes, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0